XML 63 R51.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED T. ROWE PRICE INVESTMENT PRODUCTS. (Statement of Cash Flows) (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Condensed Cash Flow Statements, Captions [Line Items]      
Net cash provided by (used in) operating activities $ 1,619.9 $ 229.5 $ 170.5
Net cash provided by (used in) investing activities (875.5) 39.0 106.2
Net cash provided by (used in) financing activities (1,239.5) 461.5 (176.4)
FX impact on cash (15.4) 5.3 (2.1)
Net change in cash and cash equivalents during period (510.5) 735.3 98.2
Cash and cash equivalents at beginning of period, including $103.1 million at December 31, 2017 and $65.6 million at December 31, 2016 held by consolidated T. Rowe Price investment products 2,005.8 1,270.5 1,172.3
Cash and cash equivalents at end of period, including $70.1 million at December 31, 2018, $103.1 million at December 31, 2017, and $65.6 million at December 31, 2016, held by consolidated T. Rowe Price investment products 1,495.3 2,005.8 1,270.5
Consolidation eliminations [Member]      
Condensed Cash Flow Statements, Captions [Line Items]      
Net cash provided by (used in) financing activities (84.9) (130.1) (277.9)
Consolidated T. Rowe Price investment products [Member] | Reportable entities [Member]      
Condensed Cash Flow Statements, Captions [Line Items]      
Net cash provided by (used in) operating activities (549.1) (1,315.3) (1,166.6)
Net cash provided by (used in) investing activities (23.8) (64.2) 41.4
Net cash provided by (used in) financing activities 555.3 1,411.7 1,192.9
FX impact on cash (15.4) 5.3 (2.1)
Net change in cash and cash equivalents during period (33.0) 37.5 65.6
Cash and cash equivalents at beginning of period, including $103.1 million at December 31, 2017 and $65.6 million at December 31, 2016 held by consolidated T. Rowe Price investment products 103.1 65.6 0.0
Cash and cash equivalents at end of period, including $70.1 million at December 31, 2018, $103.1 million at December 31, 2017, and $65.6 million at December 31, 2016, held by consolidated T. Rowe Price investment products 70.1 103.1 65.6
Voting interest entities [Member] | Reportable entities [Member]      
Condensed Cash Flow Statements, Captions [Line Items]      
Net cash provided by (used in) operating activities (43.9) (33.0) (80.1)
Net cash provided by (used in) investing activities (0.8) (9.0) 21.6
Net cash provided by (used in) financing activities 56.1 38.8 68.8
FX impact on cash 0.0 0.0 0.0
Net change in cash and cash equivalents during period 11.4 (3.2) 10.3
Cash and cash equivalents at beginning of period, including $103.1 million at December 31, 2017 and $65.6 million at December 31, 2016 held by consolidated T. Rowe Price investment products 7.1 10.3 0.0
Cash and cash equivalents at end of period, including $70.1 million at December 31, 2018, $103.1 million at December 31, 2017, and $65.6 million at December 31, 2016, held by consolidated T. Rowe Price investment products 18.5 7.1 10.3
Variable interest entities [Member] | Reportable entities [Member]      
Condensed Cash Flow Statements, Captions [Line Items]      
Net cash provided by (used in) operating activities (505.2) (1,282.3) (1,086.5)
Net cash provided by (used in) investing activities (23.0) (55.2) 19.8
Net cash provided by (used in) financing activities 499.2 1,372.9 1,124.1
FX impact on cash (15.4) 5.3 (2.1)
Net change in cash and cash equivalents during period (44.4) 40.7 55.3
Cash and cash equivalents at beginning of period, including $103.1 million at December 31, 2017 and $65.6 million at December 31, 2016 held by consolidated T. Rowe Price investment products 96.0 55.3 0.0
Cash and cash equivalents at end of period, including $70.1 million at December 31, 2018, $103.1 million at December 31, 2017, and $65.6 million at December 31, 2016, held by consolidated T. Rowe Price investment products $ 51.6 $ 96.0 $ 55.3